Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #49113 on Medizone Intl. (fka MZEIQ)
Tane61
11/16/18 11:21 AM
#49114 RE: futurist7 #49113
The US granted Medizone patent for wound resolution "Method for the application of ozone/oxygen for the treatment of external pathogenic conditions" (09/126.504) is not flawed in any way. It has about 6 years of life to go. Human need for this technology would include the thousands of veterans with poorly healing war wounds, and those who fight ongoing battles with non-healing diabetic and vascular ulcers that too often end up with limb amputations.
U.S. patent (U.S. Patent No. 6,073,627) entitled “External Application of Ozone/Oxygen for Pathogenic Conditions, a process patent for the treatment of external afflictions.” Application number US 09/126,504